1. Angelini Pharma
  2. Therapeutic areas
  3. Dialysis
  4. Alcavis®-50

Alcavis®-50

Sub Page Banner Alcavis 50 New 1030X302

High-level disinfectant ready to combat the next era of catheter related infection

Infections are the second leading cause of death in patients with end-stage renal disease (ESRD).1 Central-line associated blood stream infections (CLABSI) are one of the deadliest healthcare-associated infections. Patients with CLABSIs are 2.3 times more likely to die from these infections.2

Alcavis50™ provides efficient, thorough disinfection that won’t damage catheters, caps, or connectors.

  • Compatible: With ALL catheters, caps & connectors on the market
  • Fast-Acting: 60-second kill time against bacteria, fungi, spores, mycobacteria, and viruses
  • Timesaving: 2-minute application time
  • Stable: 30-month shelf life; 180 days once opened

References

  1. Soi et al. Prevention of catheter-related bloodstream infections in patients on hemodialysis: challenges and management strategies. Int. J. Nea-> Nephr. Renovascular Diseases, 2016.
  2. Stevens et al. Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections. Clin. Micro. & Inf. 2014

See also